Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update

Sang Joon An1, Tae Jung Kim1, Byung-Woo Yoon1

  • 1Department of Neurology, Seoul National University Hospital, Seoul, Korea.

Journal of Stroke
|February 9, 2017
PubMed

Insights

Intracerebral hemorrhage (ICH) is a severe stroke subtype with high fatality. Understanding risk factors like hypertension and anticoagulation use is crucial for managing this critical condition.

Area of Science:

  • Neurology
  • Vascular Neurology
  • Public Health

Background:

  • Intracerebral hemorrhage (ICH) is a major cause of stroke-related disability and death.
  • ICH disproportionately affects certain demographics, including Asians, older adults, and males, particularly in low- and middle-income countries.
  • High case fatality rates and limited functional independence in survivors underscore the critical nature of ICH.

Purpose of the Study:

  • To summarize the epidemiology, risk factors, clinical presentation, and emerging management challenges of intracerebral hemorrhage.
  • To highlight the increasing incidence of anticoagulation-related ICH and the need for strategies for novel oral anticoagulants.

Main Methods:

  • Review of existing literature on intracerebral hemorrhage.
  • Analysis of demographic data, risk factors, and clinical outcomes associated with ICH.
  • Examination of trends in anticoagulation use and associated ICH management.

Main Results:

  • Key risk factors for ICH include hypertension, smoking, alcohol consumption, and hypocholesterolemia.
  • Advanced age, male sex, Asian ethnicity, chronic kidney disease, cerebral amyloid angiopathy (CAA), and cerebral microbleeds (CMBs) are significant risk factors.
  • Clinical presentation is variable, influenced by hematoma size, location, and intraventricular extension; CAA-related ICH often presents with cognitive impairment.

Conclusions:

  • ICH is a critical neurological emergency with significant mortality and morbidity.
  • Emerging challenges include managing anticoagulation-related ICH, particularly with the increasing use of non-vitamin K antagonist oral anticoagulants (NOACs).
  • Further research and clinical strategies are needed to address the growing burden of NOAC-associated ICH.

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
662
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
452
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.6K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
406